The role of germinal centers for antiviral B cell responses. by Bachmann, M

Use of virus-like particles for therapeutic vaccination against addiction and other chronic diseases by Bachmann, M

Taurine: energy drink for T cells. by Bachmann, M

Vaccines against non-communicable diseases. by Röhn, T, Bachmann, M

In vivo versus in vitro assays for assessment of T- and B- cell function. by Bachmann, M, Kündig, T

Loading of MHC class I and II presentation pathways by exogenous antigens: a quantitative in vivo comparison. by Storni, T, Bachmann, M

On the role of APC-activation for in vitro versus in vivo T cell priming. by Storni, T, Bachmann, M

Allergen-specific immunotherapy: regulatory T cells or allergen-specific IgG? by Kündig, T, Bachmann, M

The role of T-cell receptor dimerization in T-cell activation. by Bachmann, M, Ohashi, P

CTL priming by CD8(+) and CD8(-) dendritic cells in vivo. by Ruedl, C, Bachmann, M

Design and analysis of studies evaluating smoking cessation interventions where effects vary between practices or practitioners. by Butler, C, Bachmann, M

Designing recombinant vaccines with viral properties: a rational approach to more effective vaccines. by Jennings, G, Bachmann, M

Immunodrugs: breaking B- but not T-cell tolerance with therapeutic anticytokine vaccines. by Link, A, Bachmann, M

Balancing protective immunity and immunopathology. by Bachmann, M, Kopf, M

Interleukin 2: from immunostimulation to immunoregulation and back again. by Bachmann, M, Oxenius, A

Therapeutic vaccination to block receptor-ligand interactions. by Spohn, G, Bachmann, M

Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns. by Bachmann, M, Jennings, G

Function of marginal zone B cells in antiviral B-cell responses. by Gatto, D, Bachmann, M

Immunodrugs: therapeutic VLP-based vaccines for chronic diseases. by Jennings, G, Bachmann, M

Challenges and new approaches for the vaccine industry. by Bachmann, M, Jennings, G